The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Fingers crossed!
Seeing new products for sale on their website as well as further details on their supply chain would satisfy my doubts as I am relatively confident in the demand that the products will receive. Having a strong cash flow from a highly regarded "original/classic" product would completely de-risk the entity from my point of view.
I imagine that the majority of managements time will be invested in servicing the current distribution agreement as well as trying to seal the deal on international distributions. Lets all hope it is carried out sucessfully!
GLA
I think you'll find that it was the old stock that has been now cleared out.
That also goes for the 8 * 10 pack cartons (which have currently disappeared from the website completely) and which previously included pictures of the old-style original CBD Smoke packets also.
I'm sure when they pop up for sale again you will see new packaging for the cartons online, which is then standard across the whole smoke range, including the new hemp smokes when they come out also...
Contract manufacturing for the stores will no doubt replace the stock online also.
Hopefully should also see the new chew flavors appearing before long.
The distribution deals (6,000 store reach) should improve sales, just need to rock and roll out into the first of 500 new stores...
Tick Tock.
Quite right BD92..............!
and an increase in demand for Chill products will require more raw material.............!
All the best (farmers........... plough your fields :()
It is still concerning. They are in a position where they need to generate as much revenue and cash flow as possible. Considering the down turn in demand due to Covid 19 I would have hoped that they may have used the time to stock pile inventory to make the most of potentially increased sales in the quarter ahead.
sold out, or prioritising the stock for the stores? :)
Sold out of smokes:
https://thechillway.com/product/cbd-smokes-calm-hemp/
https://thechillway.com/product/cbd-smokes-mint-blend/
Top 5 CBD Oils
1. Zoetic 500mg CBD Oil 30ml – Refreshing Peppermint
https://www.unfashionablemale.co.uk/review-of-the-best-5-cbd-oils/